< Back to Search

Neurology® Podcast - December 5 2017 Issue

Long-term benefit of enzyme-replacement therapy in Pompe disease: A 5-year prospective study

Show description/summary: 1) Long-term benefit of enzyme-replacement therapy in Pompe disease: A 5-year prospective study 2) What’s Trending: ACTH or prednisolone for infantile ataxia This podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the December 5, 2017 issue of Neurology. In the first segment, Dr. Kelly Gwathmey talks with Dr. Nadine van der Beek about her paper on enzyme-replacement therapy in Pompe disease. In the second part of the podcast, Dr. Ted Burns focuses his interview with Dr. John Mytinger on the topic of ACTH or prednisolone for infantile ataxia. Read More

Download this Episode

Episode Segments

Top

FOR MORE INFORMATION

Email pbaskin@neurology.org

Footer